Connect with us

Health

Experts Weigh in on Booster COVID-19 Vaccine Doses for Immunocompromised Patients – Contagionlive.com

A quartet of infectious disease, vaccinology, and virology experts share thoughts on the FDA’s newest emergency authorization…

Published

on

Article feature image

On Thursday, the US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Pfizer-BioNTech and Moderna for the use of third “booster” doses of the companies’ COVID-19 mRNA vaccines in severely immunocompromised patients in the US.

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending